BIOVANTAGE.DK ApS: Financial statements 2022
CVR: 36498544
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
BIOVANTAGE.DK ApS (CVR 36498544) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -94,000 and a net result of DKK -264,925 compared with DKK 2,088,247 the year before. Equity in the 2022 report amounted to DKK -5,179,570. The company had 1 employee in the financial year.
- Gross Profit
- DKK -94,000
- Profit/Loss
- DKK -264,925
- Equity
- DKK -5,179,570
- Total Assets
- DKK 6,805,434
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -94 t. | -265 t. | -5.2 mio. | 1 |
| 2021 | - | 4.1 mio. | 2.1 mio. | -4.9 mio. | 2 |
| 2020 | - | 3.3 mio. | -1.1 mio. | -7 mio. | 2 |
| 2019 | - | 2.7 mio. | -1.9 mio. | -5.9 mio. | 1 |
| 2018 | - | 3 mio. | -1.5 mio. | -4 mio. | 2 |
Official annual report
Keep an eye on BIOVANTAGE.DK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BIOVANTAGE.DK ApS
BIOVANTAGE.DK ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company has been dissolved on 30 December 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2021). In 2023, the company reported a gross profit of DKK -243,628 and a net result of DKK -612,916 compared with DKK -264,925 the year before. Equity in the 2023 report amounted to DKK -5,792,487.